On January 17th, Medtronic announced that its DEFINE AFib clinical study of 973 patients involving the company’s LINQ family of insertable cardiac monitors and AI-based algorithms helped detect ...

Meanwhile, the Pause algorithm reduced LINQ II false pause alerts by 97.4% and preserved 100% of true pause alerts. The AccuRhythm algorithms will be released later this year for use by all ...

The GI Genius has the power to eliminate or reduce this miss rate. Another Medtronic innovation is the LINQ II, an insertable cardiac monitor with AI algorithms for long-term heart management.